Blog
2 Warren Buffett Stocks to Buy Hand Over Fist and 1 to Avoid
For decades, Warren Buffett's Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) has captured the attention of investors with its long track record of stellar returns. Since taking over as CEO in 1965
Protalix Revenue Jumps 16 Percent in Q2
Protalix BioTherapeutics (NYSEMKT:PLX), a biopharmaceutical company specializing in plant cell-based protein production, announced its second quarter results on August 14, 2025. Revenues from
POAI Reports Earnings
Predictive Oncology (NASDAQ:POAI), a company focused on AI-driven drug discovery and oncologic assay commercialization, released its earnings for the quarter ended June 30, 2025, on August 14, 2025
Abvc BioPharma Doubles Assets in Q2
Abvc BioPharma (NASDAQ:ABVC), a clinical-stage biotechnology company focused on botanical drug development, released its second quarter results on August 14, 2025. The main headlines were a sizable
Want Decades of Passive Income? Buy This ETF and Hold It Forever.
It's smart to seek passive income in your investing life because it's money that simply flows to you with little effort expended on your part. Sources of passive income include interest paid on
Advance Auto Parts Posts Q2 EPS Beat
Advance Auto Parts (NYSE:AAP), a leading U.S. retailer of automotive replacement parts and accessories, released its second quarter 2025 results on August 14, 2025. The company reported adjusted
Amcor Posts 44 Percent Sales Gain
Amcor (NYSE:AMCR), a global leader in consumer packaging and dispensing solutions, released its Q4 and fiscal 2025 results on August 14, 2025. The headline news was the integration of the all-stock
Could Wolfspeed Make for a Good Contrarian Stock to Buy?
Taking a contrarian position in a stock comes with risks, sometimes substantial ones. That's because you're effectively going against the market, and are willing to believe that the company can do
Shattuck Labs Narrows Loss in Fiscal Q2
Shattuck Labs (NASDAQ:STTK), a clinical-stage biotechnology company focused on developing novel immunotherapies, released its second quarter 2025 earnings results on August 14, 2025, which exceeded
Should You Buy XRP While It's Less Than $4?
Cryptocurrency investors are enjoying a huge bull market right now. Ironically, it's not Bitcoin stealing the show (though the flagship crypto's price has doubled during the past year), but XRP
Deere Beats Fiscal Q3 EPS as Sales Fall
Deere & Company (NYSE:DE), a leading manufacturer of agricultural, construction, and forestry equipment, reported results for fiscal Q3 2025 (ended July 27, 2025) on August 14, 2025. The company
Battalion Oil Reports 13 Percent Q2 Drop
Battalion Oil (NYSEMKT:BATL), an independent oil and gas exploration and production company focused on the Delaware Basin, released its second quarter 2025 results on August 14, 2025. The most
22nd Century Group Sales Drop 49 Percent
22nd Century Group (NASDAQ:XXII), a tobacco harm reduction company developing and marketing very low nicotine content (VLNC) cigarettes under its VLN® brand, reported its second quarter 2025
Battalion Oil Posts Q2 Revenue Drop 13%
Battalion Oil (NYSEMKT:BATL), an independent oil and gas producer focused on the Delaware Basin, reported its second-quarter 2025 results on August 14, 2025. The company's main news this quarter
1 Dividend-Paying Dow Jones Stock to Buy in August
With just 30 components, the Dow Jones Industrial Average isn't as representative of the broader market as the S&P 500 or Nasdaq Composite. But it's still an excellent resource for finding
CaliberCos Sales Drop 38 Percent
CaliberCos (NASDAQ:CWD), an alternative asset manager specializing in middle-market real estate, reported its second quarter 2025 results on August 13, 2025. The company’s headline results fell
BCG Reports Earnings
Binah Capital Group (NASDAQ:BCG), a wealth management and brokerage platform serving financial advisors and their clients, released its second quarter 2025 financial results on August 13, 2025. In
Ten Posts 9 Percent Revenue Gain in Q2
Ten (NASDAQ:XHLD), a virtual event technology specialist, reported second-quarter earnings for fiscal 2025 on August 14, 2025. The most significant takeaway from this period was a healthy
Rockwell Medical Tops Q2 EPS View
Rockwell Medical (NASDAQ:RMTI), a key supplier of hemodialysis concentrates, released its second quarter 2025 earnings on August 14, 2025. The most notable development was a steep year-over-year
Barnwell Revenue Drops 29% in Fiscal Q3
Barnwell Industries (NYSEMKT:BRN), a diversified energy and land investment company, reported third quarter fiscal 2025 results on August 13, 2025. The company’s revenue fell sharply, as did
More Americans Are Saving for Retirement in a Roth 401(k). Here's Why You Should, Too.
Roth IRAs are a retirement savings tool many people know about and are comfortable with. But Roth 401(k)s don't tend to be as well known, even though they've been around for a long time.
During the
Should Investors Buy Shopify Stock?
Shopify (NASDAQ: SHOP) is accelerating revenue growth, and that is exciting stock market investors.
*Stock prices used were the afternoon prices of Aug. 11, 2025. The video was published on Aug
Tesla CEO Elon Musk Just Delivered Incredible News for Nvidia Stock Investors
Most investors know Tesla (NASDAQ:TSLA) for its electric vehicles (EVs) and energy storage solutions. For years, however, its CEO, Elon Musk, has been describing a vision to transform Tesla from a
The Best Stocks to Invest $1,000 in Right Now
Whether you're just getting started in investing or you've been doing it for years, it can be overwhelming to whittle so many investment opportunities down to just a few to choose from. That's why
1 Top Cryptocurrency to Buy Before It Soars 17,888%, According to Strategy's Michael Saylor
In 2020, Michael Saylor, then the chief executive officer of the business software company Strategy (NASDAQ: MSTR), made a bold decision. He decided to use the company's capital to begin